GAIA-202
Not Specified (ES/iPS-derived)
PreclinicalActive
Key Facts
About GAIA BioMedicine
A biotech company developing off-the-shelf, non-genetically modified NK-like cell therapies to eliminate solid tumors.
View full company profileTherapeutic Areas
Other Not Specified (ES/iPS-derived) Drugs
| Drug | Company | Phase |
|---|---|---|
| GAIA-251 | GAIA BioMedicine | Preclinical |